UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BNTX — BioNTech SE
CIK 861177
NEW YORK, NY
Position in BNTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$69,247,807
-$433,665 QoQ
Shares Held
744,200
-5.1% QoQ
Ownership
0.296%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 282 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. BNTX ranks #12 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in BNTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,247,807 | 744,200 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $69,681,472 | 783,995 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $23,831,511 | 250,331 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $27,349,374 | 256,874 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $19,889,506 | 218,422 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $25,192,065 | 221,080 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $21,893,347 | 184,334 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,607,115 | 231,547 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $19,740,484 | 213,989 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $105,039,000 | 995,253 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $93,228,111 | 858,138 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $49,736,625 | 460,823 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $57,404,720 | 460,823 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $72,150,815 | 480,301 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $45,783,126 | 339,436 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,531,653 | 204,773 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $30,713,249 | 180,073 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $39,089,440 | 151,627 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $25,450,037 | 93,227 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $28,320,371 | 126,498 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $35,796,629 | 327,838 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $22,930,106 | 281,282 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $9,705,492 | 140,192 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $13,495,228 | 202,206 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||